Gender and risk of cessation of oral vinorelbine in a randomized trial of concurrent chemoradiation of locally advanced NSCLC

Category Primary study
JournalJournal of Thoracic Oncology
Year 2017
This article has no abstract
Epistemonikos ID: bff67b6c31ec7da769b1af9777e6bc0ea52c4858
First added on: Feb 08, 2025